• AAPL 169.89
  • TSLA 170.18
  • AMZN 173.67
  • MSFT 399.04
  • INTC 35.11
  • EURUSD 1.0728
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. RVPH.NASDAQ

Reviva Pharmaceuticals Holdings Inc. (RVPH NASDAQ) stock market data APIs

$3.01 0.03(1%) as of April 25, 2024

Reviva Pharmaceuticals Holdings Inc. Financial Data Overview

2.98
3.01
-
3.1
2.9
2.67-9.25
84 314 K
27 919 K
0
-0.35
-0.023
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'RVPH',
Type: 'Common Stock',
Name: 'Reviva Pharmaceuticals Holdings Inc.',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
ISIN: NULL,
CUSIP: NULL,
CIK: '1742927',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2018-10-18',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Reviva Pharmaceuticals Holdings Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -10 103 922
  • Earnings Per Share -1.65
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Reviva Pharmaceuticals Holdings Inc. Earnings via APIs

  • Latest Release 2024-03-19
  • EPS/Forecast -0.35

Get Reviva Pharmaceuticals Holdings Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Reviva Pharmaceuticals Holdings Inc. latest news via APIs

Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs

Some of the worst and most deadly diseases affect our brains. In multiple sclerosis, the immune system “causes communication problems between your brain and the rest of your body,” preventing some...

Reviva Announces Closing of $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

CUPERTINO, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapi...
  • FINANCING AGREEMENTS
  • NASDAQ:RVPH
  • REVIVA PHARMACEUTICALS
Do you have any questions?
support@eodhistoricaldata.com